Can Joggers Outrun Injury (Economist)

note Partial capture Only the opening paragraph was captured. The Economist's framing below is from that lede; the study findings come from the paper's own summaries (BJSM blog, co-author institution's press release), not from the article. Treat the pairing as probable, not confirmed.

Summary

The lede establishes the problem: "runner's knee" (ache around the kneecap) was among the most common complaints in a 2021 Orthopaedic Journal of Sports Medicine study of 3,669 runners, and it is one of a family of overuse injuries — damage from training that is tolerable in parts but cumulatively exceeds the body's capacity to recover. The question in the headline — can joggers outrun injury — points at the largest wearable-based cohort on the subject, the Garmin-RUNSAFE Running Health Study (BJSM, 2025), whose answer is that risk is driven less by weekly mileage than by how far a single run exceeds your recent longest run. See Running Injury.

The underlying study

Schuster Brandt Frandsen J, Hulme A, et al. "How much running is too much? Identifying high-risk running sessions in a 5200-person cohort study." British Journal of Sports Medicine 2025;59(17):1203–1210, online 7 July 2025 (PubMed 40623829; BJSM blog summary). Aarhus University with the Luxembourg Institute of Health and others; sponsored by Garmin.

• Design: prospective cohort, 5,205 adult recreational runners (mean age 45.8, 22% female) in 87 countries, tracked by Garmin GPS watches for 18 months (July 2019 – Jan 2021); 588,071 sessions analysed. Outcome: self-reported running-related injury; 1,820 runners (35%) were injured, most classified as overuse.
• Exposure: each session's distance versus the longest run in the preceding 30 days, in bands: ≤10% (reference), small spike >10–30%, moderate >30–100%, large >100%. Weekly measures (week-to-week change, acute:chronic workload ratio) were tested in parallel.
• Findings (hazard rate ratios vs reference):
  • Small spike 1.64 — 64% higher injury rate
  • Moderate spike 1.52
  • Large spike 2.28 (95% CI 1.50–3.48) — more than double
  • Weekly change: no association. Acute:chronic ratio: a negative dose-response (i.e. no support as a risk flag).
• Authors' reading of the "10% rule": since even >10% jumps in the longest run carried risk, the safe increase in a single session "may be vastly less than 10%"; the rule-of-thumb is aimed at the wrong unit (the week, not the session).

What the authors or summaries flag as unproven

• Injury is self-reported; biomechanical factors and running intensity/pace were not measured, so a distance spike may be a proxy for other load.
• The study is observational and exploratory; the authors call for triangulation in other cohorts before the session-spike rule is used prescriptively. An industry sponsor (Garmin) funded the cohort.
• The 2021 OJSM prevalence study cited in the lede is not identified beyond the Economist's description (n = 3,669); its injury taxonomy is not paged here.

Connections

• Running Injury — concept page; this is its anchor source.
• Minimum Effective Dose of Exercise — the inverse question: here, the dose at which more running starts to cost.
• Step Count Targets — the walking counterpart; the same wearable-cohort method.
• The Economist — Science & technology.

Captured-by trigger

Source file: raw/processed/Economist 2026-10-24 Science---Techn - Can joggers outrun injury.md (lede only).